Ingredion Takes 9% Stake in Sanstar to Expand India Pharma, Food Ingredients Play — Ingredion Incorporated

Event summary

Ingredion forms joint venture with Sanstar Limited, acquiring 9% equity stake in the Indian corn-based specialty products manufacturer.
Partnership targets India's fast-growing specialty starch and functional ingredients market, driven by domestic consumption and pharmaceutical exports.
Companies will build a new manufacturing facility for specialty pharmaceutical and food ingredients, serving high-value markets.
Deal combines Sanstar's local manufacturing with Ingredion's global formulation expertise to create vertically integrated solutions.
India's specialty ingredients market is among the fastest-growing in Asia-Pacific, with rising demand for clean-label and sustainable formulations.

The big picture

Ingredion's move into India's high-growth specialty ingredients market aligns with broader trends in Asia-Pacific, where rising pharmaceutical exports and domestic consumption are driving demand. The partnership with Sanstar provides Ingredion with a local manufacturing foothold, addressing regulatory and supply chain complexities in the region. With Ingredion's 2025 net sales at $7.2 billion, this deal represents a strategic bet on India's long-term potential as a key market for ingredient solutions.

What we're watching

Market Penetration: How Ingredion will leverage Sanstar's local expertise to capture India's rapidly evolving consumer needs.
Execution Risk: The pace at which the new manufacturing facility can be operationalized to meet demand.
Regulatory Dynamics: Whether India's focus on clean-label and sustainable formulations will accelerate or hinder the partnership's growth.